Matches in Wikidata for { <http://www.wikidata.org/entity/Q84430533> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q84430533 description "artículu científicu espublizáu en xunu de 2012" @default.
- Q84430533 description "scientific article published on 19 June 2012" @default.
- Q84430533 description "wetenschappelijk artikel" @default.
- Q84430533 description "наукова стаття, опублікована в червні 2012" @default.
- Q84430533 name "Flecainide, a therapeutic option in a patient with long QT syndrome type 3 caused by the heterozygous V411M mutation in the SCN5A gene" @default.
- Q84430533 name "Flecainide, a therapeutic option in a patient with long QT syndrome type 3 caused by the heterozygous V411M mutation in the SCN5A gene" @default.
- Q84430533 type Item @default.
- Q84430533 label "Flecainide, a therapeutic option in a patient with long QT syndrome type 3 caused by the heterozygous V411M mutation in the SCN5A gene" @default.
- Q84430533 label "Flecainide, a therapeutic option in a patient with long QT syndrome type 3 caused by the heterozygous V411M mutation in the SCN5A gene" @default.
- Q84430533 prefLabel "Flecainide, a therapeutic option in a patient with long QT syndrome type 3 caused by the heterozygous V411M mutation in the SCN5A gene" @default.
- Q84430533 prefLabel "Flecainide, a therapeutic option in a patient with long QT syndrome type 3 caused by the heterozygous V411M mutation in the SCN5A gene" @default.
- Q84430533 P1433 Q84430533-A9892EE1-CBA1-4215-BF2D-AECEC039BF76 @default.
- Q84430533 P1476 Q84430533-C7C79C7E-AA23-44D6-8D05-5BE2348EE552 @default.
- Q84430533 P2093 Q84430533-276B4DF3-0ADA-4E99-B58D-3BDCB94AE5BE @default.
- Q84430533 P2093 Q84430533-5165D245-CF91-4B4C-B3DD-404F1DCAD307 @default.
- Q84430533 P2093 Q84430533-60566AA3-11A1-4A88-AFC8-C5EDF537D95E @default.
- Q84430533 P2093 Q84430533-963F7E20-D84C-439A-9199-C287178C0133 @default.
- Q84430533 P2093 Q84430533-CEE50D5D-447B-4EEC-AF42-C850ABE40F54 @default.
- Q84430533 P304 Q84430533-993AABC9-8356-4308-8F54-F9591367748E @default.
- Q84430533 P31 Q84430533-6DA68860-31AD-4E0C-B81C-FEF67667985E @default.
- Q84430533 P356 Q84430533-B8A46EF0-9ACF-47EA-8B6B-D48DE606F096 @default.
- Q84430533 P433 Q84430533-29FAB138-E83B-41F5-940F-85267673D524 @default.
- Q84430533 P478 Q84430533-5E18CA22-9EA4-4967-9DE4-185262807061 @default.
- Q84430533 P50 Q84430533-BFC9A098-EF9A-4F37-9ABA-00F49DA9A62E @default.
- Q84430533 P577 Q84430533-9148D549-0ED6-4715-B09F-5EE2A80709B4 @default.
- Q84430533 P698 Q84430533-3C59F733-756D-4A4C-A71C-EDC652774952 @default.
- Q84430533 P921 Q84430533-0AC3B44A-91AB-4546-BB37-CFB33394775C @default.
- Q84430533 P921 Q84430533-2BDE0A7F-C74F-4398-B77A-C96042B50B99 @default.
- Q84430533 P356 J.REC.2012.03.013 @default.
- Q84430533 P698 22721569 @default.
- Q84430533 P1433 Q2467119 @default.
- Q84430533 P1476 "Flecainide, a therapeutic option in a patient with long QT syndrome type 3 caused by the heterozygous V411M mutation in the SCN5A gene" @default.
- Q84430533 P2093 "Antonio Salvador" @default.
- Q84430533 P2093 "Esther Zorio" @default.
- Q84430533 P2093 "Isabel Izquierdo" @default.
- Q84430533 P2093 "Miguel Ángel Arnau" @default.
- Q84430533 P2093 "Pilar Medina" @default.
- Q84430533 P304 "1058-1059" @default.
- Q84430533 P31 Q13442814 @default.
- Q84430533 P356 "10.1016/J.REC.2012.03.013" @default.
- Q84430533 P433 "11" @default.
- Q84430533 P478 "65" @default.
- Q84430533 P50 Q72120795 @default.
- Q84430533 P577 "2012-06-19T00:00:00Z" @default.
- Q84430533 P698 "22721569" @default.
- Q84430533 P921 Q124059385 @default.
- Q84430533 P921 Q653924 @default.